Table 4 Association of copeptin levels and IMT according to categories of glucose homeostasis
|  | Copeptin | Copeptin | Copeptin | β per 1 SD increase in copeptin |
|---|---|---|---|---|
Q3-4 vs Q1-2 | Q4 vs Q1-Q3 | Q4 vs Q1 | ||
Total study cohort | Â | |||
No adjustment | Â | |||
NGT (n = 911) | 0.007 | 0.019 | 0.024 | 0.001 |
(-0.010; 0.025) | (-0.002; 0.040) | (-0.001; 0.049) | (-0.008; 0.010) | |
Prediabetes (n = 224) | -0.010 | -0.009 | -0.024 | -0.011 |
(-0.046; 0.027) | (-0.049; 0.031) | (-0.075; 0.027) | (-0.055; 0.032) | |
T2D (n = 140) | -0.018 | -0.003 | 0.001 | 0.009 |
(-0.068; 0.032) | (-0.051; 0.046) | (-0.076; 0.077) | (-0.006; 0.024) | |
Adjustment for age and sex | Â | |||
NGT | -0.015 | -0.004 | -0.007 | -0.004 |
(-0.029; -0.002) | (-0.020; 0.012) | (-0.026; 0.012) | (-0.011; 0.002) | |
Prediabetes | -0.028 | -0.040 | -0.058 | -0.044 |
(-0.060; 0.004) | (-0.075; -0.005) | (-0.103; -0.014) | (-0.082; -0.006) | |
T2D | -0.025 | -0.009 | -0.008 | 0.010 |
(-0.071; 0.020) | (-0.054; 0.035) | (-0.078; 0.062) | (-0.003; 0.024) | |
Adjusted for age, sex and BMI | Â | |||
NGT | -0.016 | -0.006 | -0.008 | -0.005 |
(-0.029; -0.003) | (-0.022; 0.010) | (-0.027; 0.011) | (-0.012; 0.002) | |
Prediabetes | -0.027 | -0.038 | -0.057 | -0.042 |
(-0.058; 0.005) | (-0.073; -0.004) | (-0.101; -0.013) | (-0.079; -0.004) | |
T2D | -0.025 | -0.008 | -0.007 | 0.010 |
(-0.070; 0.021) | (-0.053; 0.037) | (-0.078; 0.063) | (-0.003; 0.024) | |
Multivariable adjustment a | Â | |||
NGT | -0.018 | -0.007 | -0.009 | -0.006 |
(-0.031; -0.005) | (-0.023; 0.008) | (-0.028; 0.010) | (-0.013; 0.0002) | |
Prediabetes | -0.031 | -0.041 | -0.066 | -0.050 |
(-0.064; 0.002) | (-0.078; -0.005) | (-0.112; -0.019) | (-0.091; -0.009) | |
T2D | -0.030 | -0.009 | -0.018 | 0.012 |
(-0.081; 0.020) | (-0.059; 0.040) | (-0.096; 0.060) | (-0.002; 0.026) | |